AstraZeneca news, latest stories & analysis

Find today's trending AstraZeneca news & headlines

AstraZeneca drug gets US FDA nod for certain type of endometrial cancer
AstraZeneca drug gets US FDA nod for certain type of endometrial cancer
  • AstraZeneca's Imfinzi approved by FDA for combination chemotherapy in advanced endometrial cancer.
  • Clinical trials show Imfinzi reduces risk of disease progression or death by 58% in dMMR patients.
  • AstraZeneca aims for $80 billion in annual revenues by 2030, driven by oncology and new drug launches.
June 17, 2024

More breaking stories

Other topics

AED
ARS
BP
BRL
BT
COP
CZK
DKK
FTX
GMX
GSK
IAC
IDR
INR
IPO
KRW
Nio
OKX
PHP
PKR
PLN
RUB
SLB
Sui
THB
TRY
TWD
WMB
ZAR